GENZYME
Live / Registered — Registered — Section 8 accepted (as of 07 Sept 2023)
What this means for you
Registered since 18 Apr 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 18 Apr 2027, and its filing window is open now).
Record
- Serial number
- 87236048
- Registration number
- 5186642
- Mark type
- Word mark
- Filed
- 14 Nov 2016
- Published for opposition
- 31 Jan 2017
- Registered
- 18 Apr 2017
- Next maintenance filing
- §8 & §9 renewal, due by 18 Apr 2027 (grace period to 18 Oct 2027)
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of pharmaceuticals
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 18 Apr 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 07 Sept 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 07 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Apr 2023 — TEAS SECTION 8 RECEIVED
- 18 Apr 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Apr 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Apr 2017 — REGISTERED-PRINCIPAL REGISTER
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Jan 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jan 2017 — PUBLISHED FOR OPPOSITION